The Prescription Drugs That Accelerate Biological Ageing

PPIs (Proton Pump Inhibitors): Microbiome Devastation and Nutrient Depletion

What They Do: PPIs (omeprazole, lansoprazole, esomeprazole) suppress stomach acid production. They're prescribed for reflux, GERD, ulcers. Effective short-term, often used chronically for years.

The Aging Mechanism: Stomach acid isn't just for digestion—it's part of your microbiome defense. Without adequate acid: (1) pathogenic bacteria colonize the small intestine (dysbiosis); (2) nutrient absorption of B12, magnesium, calcium, iron declines dramatically; (3) intestinal barrier integrity suffers from dysbiosis, leading to "leaky gut."

The Evidence: Xie et al. (2016) showed that long-term PPI use increased risk of chronic kidney disease by 20-50% in large cohorts. Roughead et al. (2016) showed increased fracture risk due to calcium malabsorption. Microbiome studies show profound dysbiosis in long-term PPI users.

B12 Depletion:10-30% of long-term PPI users become B12 deficient. B12 is critical for neurological function, energy, and cognitive health. Deficiency causes permanent nerve damage if untreated.

What to Do: Short-term PPI use (4-8 weeks) is reasonable for acute reflux. Long-term use (>1 year) should be questioned. Safer alternatives: H2 blockers (ranitidine, famotidine) reduce acid but don't abolish it, preserving microbiome; dietary changes (smaller meals, avoid trigger foods, eat 2-3 hours before bed); melatonin and zinc carnosine promote healing without microbiome damage.

Benzodiazepines: Dementia Risk and GABA Downregulation

What They Do: Benzodiazepines (diazepam, lorazepam, alprazolam) enhance GABA, the inhibitory neurotransmitter. Used for anxiety, insomnia, seizures.

The Aging Mechanism: Chronic benzodiazepine use causes GABA receptor downregulation—your brain adapts by reducing GABA sensitivity, so you need higher doses for the same effect. Discontinuation then causes rebound anxiety. Additionally, chronic benzodiazepines impair cognition acutely and are associated with dementia and cognitive decline.

The Evidence: Billioti de Gage et al. (2012), a large prospective cohort of 1.3 million, showed that long-term benzodiazepine use (>6 months) was associated with 30-60% increased dementia risk, persisting years after discontinuation. The association was dose-dependent.

What to Do: Benzodiazepines are appropriate for acute anxiety or insomnia (short-term, 2-4 weeks). Long-term use is aging. If you've been on them chronically, tapering (slowly, over weeks to months) with medical supervision is necessary. Safer alternatives: CBT for anxiety, sleep hygiene for insomnia, magnesium glycinate, L-theanine.

Anticholinergics: The Gray 2015 Dementia Study

What They Do: Anticholinergic drugs block acetylcholine. Include: antihistamines (diphenhydramine), antidepressants (tricyclics), antipsychotics, urinary antimuscarinics, antiParkinson drugs.

The Aging Mechanism: Acetylcholine is critical for cognition, memory, and attention. Blocking it chronically impairs these functions. Additionally, acetylcholine is neuroprotective against amyloid and tau. Long-term anticholinergic use may accelerate Alzheimer's pathology.

The Evidence: Gray et al. (2015) examined 3,500 people age 65+ and found that cumulative anticholinergic drug exposure was associated with increased dementia risk (20-46% increased risk). Association was strongest with tricyclic antidepressants and antihistamines.

What to Do: Avoid long-term anticholinergic use in older adults. If you're on a tricyclic antidepressant for depression, consider switching to a newer SSRI (no anticholinergic effects). If using antihistamines for allergies, try non-sedating alternatives (cetirizine, fexofenadine) or intranasal corticosteroids.

Long-Term Antibiotics: Microbiome Devastation

What They Do: Antibiotics kill bacteria. Essential for acute infections. Increasingly, prescribed chronically for acne, rosacea, or recurrent infections.

The Aging Mechanism: Broad-spectrum antibiotics kill your commensal (good) bacteria along with pathogens. Dysbiosis from antibiotic use is associated with: increased inflammatory markers, impaired immune function, altered metabolism, increased cancer risk, and increased neuroinflammation.

The Evidence: Cao et al. (2016) showed that people who used antibiotics had different microbiome composition years later, with reduced microbial diversity and altered metabolic capacity. Reduced microbiome diversity is associated with aging and disease risk.

What to Do: Use antibiotics only for acute infections with clear indication. Avoid chronic low-dose antibiotics unless absolutely necessary. If you require long-term antibiotics, aggressive probiotic supplementation and post-treatment microbiome restoration is critical.

Statins at Wrong Doses: CoQ10 Depletion and Muscle Damage

What They Do: Statins inhibit HMG-CoA reductase, reducing cholesterol synthesis.

The Aging Mechanism: HMG-CoA reductase is also required for CoQ10 synthesis. Statins reduce CoQ10 production, leading to mitochondrial dysfunction and muscle damage. High-dose statins also directly impair muscle protein synthesis.

The Evidence: Golomb & Evans (2008) showed that statin use is associated with myopathy (muscle pain and weakness) in 10-25% of users, dose-dependent. CoQ10 depletion is well-documented.

What to Do: If on statins, ensure adequate CoQ10 supplementation (100-300 mg daily of ubiquinol, the active form). Low-dose statins (20 mg atorvastatin or equivalent) are often as effective as high doses for most people. If you have muscle pain on statins, dosing reduction is warranted. In many cases, lifestyle (exercise, nutrition) alone can manage lipids.

Fluoroquinolone Antibiotics: Mitochondrial Toxicity and Tendon Damage

What They Do: Fluoroquinolones (cipro, levofloxacin, moxifloxacin) are broad-spectrum antibiotics.

The Aging Mechanism: Fluoroquinolones are mitochondrial toxins. They damage mitochondrial DNA and impair mitochondrial function. They also damage tendons by inhibiting collagen cross-linking and reducing tendon strength.

The Evidence: FDA black box warning (2016) on fluoroquinolone tendinopathy risk. Studies show tendon rupture risk increased 3-6 fold, particularly in older people. Mitochondrial damage is dose and duration dependent.

What to Do: Avoid fluoroquinolones unless absolutely necessary (no other option). Use the shortest duration possible. If on fluoroquinolones, avoid intense exercise and strenuous activity. Ensure adequate protein intake to support collagen synthesis. Safer alternatives: penicillins, cephalosporins (unless allergy).

The Honest Assessment

These drugs all treat real problems. They're not evil. But when used chronically, side effects accumulate and age tissues. The key: use them appropriately (short-term when necessary, not long-term as defaults) and mitigate damage with targeted strategies (nutrient supplementation, microbiome support, exercise, lifestyle).

Many people have been on PPIs or benzodiazepines for years without recognizing the aging cost. The conversation with your doctor should be: "Is this still needed? Can we taper and try alternatives?" Often the answer is yes.